Skip to Content
You are currently on the new version of our website. Access the old version .

11 Results Found

  • Article
  • Open Access
22 Citations
4,466 Views
32 Pages

Differential Sensitivity of the Protein Translation Initiation Machinery and mTOR Signaling to MECP2 Gain- and Loss-of-Function Involves MeCP2 Isoform-Specific Homeostasis in the Brain

  • Marjorie Buist,
  • Nada El Tobgy,
  • Danilo Shevkoplyas,
  • Matthew Genung and ,
  • Annan Ali Sher,
  • Shervin Pejhan and
  • Mojgan Rastegar
  • + 2 authors+ 0 author

24 April 2022

Eukaryotic gene expression is controlled at multiple levels, including gene transcription and protein translation initiation. One molecule with key roles in both regulatory mechanisms is methyl CpG binding protein 2 (MeCP2). MECP2 gain- and loss-of-f...

(This article belongs to the Special Issue Transcriptional Regulatory Mechanisms in Health and Disease)
  • Feature Paper
  • Article
  • Open Access
18 Citations
4,983 Views
19 Pages

22 August 2021

Methyl CpG binding protein 2 (MeCP2) is the main DNA methyl-binding protein in the brain that binds to 5-methylcytosine and 5-hydroxymethyl cytosine. MECP2 gene mutations are the main origin of Rett Syndrome (RTT), a neurodevelopmental disorder in yo...

(This article belongs to the Collection DNA Methylation Dynamics in Health and Disease)
  • Article
  • Open Access
35 Citations
7,620 Views
15 Pages

DNA Methylation Contributes to the Differential Expression Levels of Mecp2 in Male Mice Neurons and Astrocytes

  • Vichithra R.B. Liyanage,
  • Carl O. Olson,
  • Robby M. Zachariah,
  • James R. Davie and
  • Mojgan Rastegar

Methyl CpG binding protein-2 (MeCP2) isoforms (E1 and E2) are important epigenetic regulators in brain cells. Accordingly, MeCP2 loss- or gain-of-function mutation causes neurodevelopmental disorders, including Rett syndrome (RTT), MECP2 duplication...

(This article belongs to the Special Issue Molecular Research on Rett Syndrome and Related Disorders: From the Past Towards the Future)
  • Article
  • Open Access
7 Citations
4,700 Views
26 Pages

9 December 2022

Methyl CpG binding protein 2 (MeCP2) is an epigenetic reader that binds to methylated CpG dinucleotides and regulates gene transcription. Mecp2/MECP2 gene has 4 exons, encoding for protein isoforms MeCP2E1 and MeCP2E2. MeCP2 plays key roles in neurod...

(This article belongs to the Special Issue Molecular Research on Rett Syndrome and Related Disorders: From the Past towards the Future 2.0)
  • Review
  • Open Access
80 Citations
22,131 Views
27 Pages

8 January 2021

Rett Syndrome (RTT) is a severe, rare, and progressive developmental disorder with patients displaying neurological regression and autism spectrum features. The affected individuals are primarily young females, and more than 95% of patients carry de ...

(This article belongs to the Collection DNA Methylation Dynamics in Health and Disease)
  • Article
  • Open Access
9 Citations
8,449 Views
18 Pages

Experimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin Damage

  • Tina Khorshid Ahmad,
  • Ting Zhou,
  • Khaled AlTaweel,
  • Claudia Cortes and ,
  • Ryan Lillico,
  • Ted Martin Lakowski,
  • Kiana Gozda and
  • Michael Peter Namaka
  • + 3 authors+ 0 author

Multiple sclerosis (MS) is a chronic neurological disease characterized by the destruction of central nervous system (CNS) myelin. At present, there is no cure for MS due to the inability to repair damaged myelin. Although the neurotrophin brain deri...

(This article belongs to the Special Issue Brain-Derived Neurotrophic Factor)
  • Review
  • Open Access
30 Citations
5,447 Views
22 Pages

The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology

  • Kazem Nejati-Koshki,
  • Chris-Tiann Roberts,
  • Ghader Babaei and
  • Mojgan Rastegar

9 May 2023

Epigenetic mechanisms are gene regulatory processes that control gene expression and cellular identity. Epigenetic factors include the “writers”, “readers”, and “erasers” of epigenetic modifications such as DNA met...

(This article belongs to the Special Issue Oncogenes and Tumor Suppressor Genes in Brain Tumor)
  • Review
  • Open Access
51 Citations
15,267 Views
32 Pages

20 February 2023

DNA methylation, one of the most well-studied epigenetic modifications, is involved in a wide spectrum of biological processes. Epigenetic mechanisms control cellular morphology and function. Such regulatory mechanisms involve histone modifications,...

(This article belongs to the Section Molecular Neurobiology)
  • Article
  • Open Access
1 Citations
2,236 Views
14 Pages

Alternative splicing is one of the processes that contributes to producing a vast protein diversity from the limited number of protein-coding genes in higher eukaryotes. The Methyl CpG Binding Protein 2 (Mecp2) gene, whose mutations cause Rett syndro...

(This article belongs to the Special Issue RNA Biology and Regulation)
  • Review
  • Open Access
45 Citations
8,010 Views
31 Pages

MeCP2 and Chromatin Compartmentalization

  • Annika Schmidt,
  • Hui Zhang and
  • M. Cristina Cardoso

3 April 2020

Methyl-CpG binding protein 2 (MeCP2) is a multifunctional epigenetic reader playing a role in transcriptional regulation and chromatin structure, which was linked to Rett syndrome in humans. Here, we focus on its isoforms and functional domains, inte...

(This article belongs to the Special Issue Nuclear Architecture, Lipids, and Phase Separation)
  • Article
  • Open Access
8 Citations
3,996 Views
17 Pages

21 April 2024

Rett Syndrome (RTT) is a progressive X-linked neurodevelopmental disorder with no cure. RTT patients show disease-associated symptoms within 18 months of age that include developmental regression, progressive loss of useful hand movements, and breath...

(This article belongs to the Special Issue Brain-Derived Neurotrophic Factor in Health and Diseases)